140 related articles for article (PubMed ID: 10798765)
21. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
22. HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.
Cole MS; Stellrecht KE; Shi JD; Homola M; Hsu DH; Anasetti C; Vasquez M; Tso JY
Transplantation; 1999 Aug; 68(4):563-71. PubMed ID: 10480417
[TBL] [Abstract][Full Text] [Related]
23. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
[TBL] [Abstract][Full Text] [Related]
24. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies.
Chavin KD; Lau HT; Bromberg JS
Transplantation; 1992 Aug; 54(2):286-91. PubMed ID: 1353913
[TBL] [Abstract][Full Text] [Related]
25. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2.
Hirahara H; Tsuchida M; Watanabe T; Haga M; Matsumoto Y; Abo T; Eguchi S
Transplantation; 1995 Jan; 59(1):85-90. PubMed ID: 7839434
[TBL] [Abstract][Full Text] [Related]
26. Selective in vivo deletion of alloactivated TH1 cells by OKT3 monoclonal antibody in acute rejection.
Reinke P; Schwinzer H; Höflich C; Ode-Hakim C; Döcke WD; Frei U; Volk HD
Immunol Lett; 1997 Jun; 57(1-3):151-3. PubMed ID: 9232443
[TBL] [Abstract][Full Text] [Related]
27. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
28. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
29. Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.
Nakamura T; Takahashi K; Fukazawa T; Koyanagi M; Yokoyama A; Kato H; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(11):3628-34. PubMed ID: 1700989
[TBL] [Abstract][Full Text] [Related]
30. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
[TBL] [Abstract][Full Text] [Related]
31. Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitro.
Choi I; De Ines C; Kürschner T; Cochlovius B; Sörensen V; Olafsen T; Sandlie I; Little M
Eur J Immunol; 2001 Jan; 31(1):94-106. PubMed ID: 11169443
[TBL] [Abstract][Full Text] [Related]
32. Activation-induced NK cell death triggered by CD2 stimulation.
Ida H; Anderson P
Eur J Immunol; 1998 Apr; 28(4):1292-300. PubMed ID: 9565369
[TBL] [Abstract][Full Text] [Related]
33. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
[TBL] [Abstract][Full Text] [Related]
34. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
[TBL] [Abstract][Full Text] [Related]
35. Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
Scott CF; Bolender S; McIntyre GD; Holldack J; Lambert JM; Venkatesh YP; Morimoto C; Ritz J; Schlossman SF
J Immunol; 1989 Jun; 142(11):4105-12. PubMed ID: 2565930
[TBL] [Abstract][Full Text] [Related]
36. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
Alegre ML; Peterson LJ; Xu D; Sattar HA; Jeyarajah DR; Kowalkowski K; Thistlethwaite JR; Zivin RA; Jolliffe L; Bluestone JA
Transplantation; 1994 Jun; 57(11):1537-43. PubMed ID: 8009586
[TBL] [Abstract][Full Text] [Related]
37. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
38. Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the rat.
Sido B; Otto G; Zimmermann R; Müller P; Meuer S; Dengler TJ
Transpl Int; 1996; 9 Suppl 1():S323-7. PubMed ID: 8959856
[TBL] [Abstract][Full Text] [Related]
39. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3.
Gray JD; Hirokawa M; Ohtsuka K; Horwitz DA
J Immunol; 1998 Mar; 160(5):2248-54. PubMed ID: 9498764
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]